• 中

    • Regis A. Vilchez

    • Dr. Regis A. Vilchez is the Chief Medical Officer of MicuRx Pharmaceuticals, Inc., responsible for overseeing new drug development programs and clinical activities in the United States, Europe and other regions
    • Prior to joining MicuRx, Dr. Vilchez served in multiple R&D roles at esteemed pharmaceutical and biotech companies including Boehringer Ingelheim, Merck, Roche, Abbott, AbbVie, and Mallinckrodt Pharmaceuticals
    • With over 20 years of medical experience, specializing in infectious diseases
    • He has co-authored more than 100 peer-reviewed scientific publications in high impact biomedical journals such as the New England Journal of Medicine, The Lancet, and Clinical Microbiology Reviews
    • Dr. Vilchez holds an M.D. from the Universidad Autónoma de Centro América in Costa Rica and a Ph.D. from Baylor College of Medicine in Houston, Texas, the United States

    Back